Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin timing study for prevention of placenta-mediated pregnancy complications in high-risk pregnancy
ChiCTR1800015301Phase 4Not yet recruiting
- Sponsor
- Xinhua Hospital
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin in Placenta-mediated pregnancy complication (PMPC) (2 arms), sponsored by Xinhua Hospital. Primary endpoint: Incidence of placenta-mediated pregnancy complications. Planned start Mar 2018; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
Placenta-mediated pregnancy complication (PMPC)
Beyond the preview
Go deeper on ChiCTR1800015301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015301.